Research
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e6409 (Published 09 October 2012) Cite this as: BMJ 2012;345:e6409Related articles
- Letter Published: 03 December 2012; BMJ 345 doi:10.1136/bmj.e8149
- Letter Published: 03 December 2012; BMJ 345 doi:10.1136/bmj.e8141
- Letter Published: 03 December 2012; BMJ 345 doi:10.1136/bmj.e8164
- Letter Published: 03 December 2012; BMJ 345 doi:10.1136/bmj.e8144
- Letter Published: 03 December 2012; BMJ 345 doi:10.1136/bmj.e8146
See more
- Abortion: MPs propose decriminalisation in England and WalesBMJ April 09, 2024, 385 q831; DOI: https://doi.org/10.1136/bmj.q831
- US president expands government research into women’s health issuesBMJ March 21, 2024, 384 q713; DOI: https://doi.org/10.1136/bmj.q713
- Tameside General Hospital must improve its maternity services, says CQCBMJ March 15, 2024, 384 q669; DOI: https://doi.org/10.1136/bmj.q669
- NHS rolls out fast tracked immunotherapy for advanced endometrial cancerBMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557
- Women from more deprived backgrounds are less likely to have an epidural, finds studyBMJ February 16, 2024, 384 q411; DOI: https://doi.org/10.1136/bmj.q411
Cited by...
- Approche pragmatique a la prise en charge de la menopause
- A pragmatic approach to the management of menopause
- Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
- A case vignette describing management of menopausal symptoms and migraine in the perimenopause
- Postmenopausal hormone therapy for cardiovascular health: the evolving data
- Risk of cardiovascular disease after preventive salpingo-oophorectomy
- 17{beta}-Estradiol nongenomically induces vascular endothelial H2S release by promoting phosphorylation of cystathionine {gamma}-lyase
- Oestrogenic vascular effects are diminished by ageing
- Sex Differences and Functional Outcome After Intravenous Thrombolysis
- Myocardial infarction in the Wisconsin Longitudinal Study: the interaction among environmental, health, social, behavioural and genetic factors
- Estrogen Signaling in the Adrenal Cortex: Implications for Blood Pressure Sex Differences
- Botanicals and Their Bioactive Phytochemicals for Womens Health
- Is there a time limit for systemic menopausal hormone therapy?
- Sex hormone therapy and progression of cardiovascular disease in menopausal women
- Protective effect of porcine placenta in a menopausal ovariectomized mouse
- Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative
- The Concurrent Use of Aromatase Inhibitors and Radiotherapy Induces Echocardiographic Changes in Patients with Breast Cancer
- Estrogen Effects on Vascular Inflammation Are Age Dependent: Role of Estrogen Receptors
- Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern
- Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Menopausal Hormone Therapy and Cardiovascular Disease Risk: Utility of Biomarkers and Clinical Factors for Risk Stratification
- While hormone therapy unlikely harmful in younger postmenopausal women at low CV risk, protective effects cannot be claimed
- Comparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment
- Is {beta} the {alpha} Dog in Estrogen Receptor-Mediated Protection From Hypertension?
- Does hormone replacement therapy cause breast cancer? Commentary on Shapiro et al. papers, Parts 1-5
- The age hypothesis does not stand up to scrutiny
- Authors' reply to Marjoribanks and colleagues, Rossouw and colleagues, Schroll and Lundh, and McPherson
- Trial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal women
- Study had insufficient power to investigate safety
- Press release was misleading
- Was the composite outcome specified in the original protocol?
- How Safe Is Hormone Therapy in Healthy, Recently Menopausal Women?